Prostock-Studio/iStock via Getty Images
ZimVie (NASDAQ:ZIMV) soared 19% after a report that the dental implants maker is considering a sale after takeover approaches.
The company is working with an adviser to review alternatives after getting interest from possible acquirers including private equity firms and industry players, according to a Bloomberg report on Tuesday, which cited people familiar with the matter.
Deliberations are at an early stage and ZimVie (ZIMV) made decide not to pursue a sale.
ZimVie, which was spun off from Zimmer Biomet in 2022, has a market cap of over $400 million.